Institutions / Privium Fund Management B.V.
Privium Fund Management B.V.
CIK 1795097 · Institution · as of Jun 30, 2026
Portfolio value
$544.22M
Positions
61
As of
Jun 30, 2026
Portfolio trend
Portfolio value
$544.22M+0.2%Positions
61+7.0%Top holdings
Jun 30, 2026View all 61 →
| Company | Value | % of portfolio |
|---|---|---|
| Tesla Inc | $95.90M | 17.6% |
| Shopify Inc | $42.25M | 7.8% |
| Advanced Micro Devices Inc | $36.02M | 6.6% |
| Amazon.com Inc | $33.37M | 6.1% |
| Ionis Pharmaceuticals Inc | $25.37M | 4.7% |
| Spotify Technology S a | $25.25M | 4.6% |
| Palantir Technologies Inc | $23.33M | 4.3% |
| Arrowhead Pharmaceuticals, Inc. | $19.09M | 3.5% |
| Opendoor Technologies Inc. | $18.21M | 3.3% |
| Lemonade, Inc. | $17.58M | 3.2% |
| NVIDIA Corp | $16.21M | 3.0% |
| Iren Limited | $15.56M | 2.9% |
| Uniqure NV | $15.12M | 2.8% |
| Cerebras Systems Inc. | $13.37M | 2.5% |
| AST SpaceMobile, Inc. | $12.88M | 2.4% |
| Ultragenyx Pharmaceutical Inc. | $11.31M | 2.1% |
| Arcutis Biotherapeutics, Inc. | $10.47M | 1.9% |
| Biogen Inc. | $10.46M | 1.9% |
| Proqr Thrapeutics N V | $10.27M | 1.9% |
| Axsome Therapeutics, Inc. | $9.78M | 1.8% |
| Urogen Pharma Ltd | $7.73M | 1.4% |
| Space Exploration Technologies CorpSPCX | $6.83M | 1.3% |
| Denali Therapeutics Inc. | $5.91M | 1.1% |
| Vertex Pharmaceuticals Inc / Ma | $4.67M | 0.9% |
| BioMarin Pharmaceutical Inc | $4.29M | 0.8% |
Activity
Jun 30, 2026View full history →
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q2 2026 as of | New | Opendoor Technologies Inc. | $18.21M | +3.9M | 3,940,904 3.35% of portfolio | medium |
| Q2 2026 as of | Exit | Coinbase Global, Inc. | $-17.87M | -79K -100.00% | — | medium |
| Q2 2026 as of | Exit | Sea Ltd | $-17.60M | -138K -100.00% | — | medium |
| Q2 2026 as of | New | Cerebras Systems Inc. | $13.37M | +61K | 60,500 2.46% of portfolio | medium |
| Q2 2026 as of | Trim | Arrowhead Pharmaceuticals, Inc. | $-13.37M | -164K -41.18% | 234,222 3.51% of portfolio | medium |
| Q2 2026 as of | New | SPCX Space Exploration Technologies Corp Common Stock | $6.83M | +40K | 40,000 1.26% of portfolio | medium |
| Q2 2026 as of | Add | Ionis Pharmaceuticals Inc | $6.27M | +79K +32.85% | 319,924 4.66% of portfolio | medium |
| Q2 2026 as of | Trim | L8681T102 | $-5.97M | -13K -19.12% | 55,000 4.64% of portfolio | medium |
| Q2 2026 as of | New | Denali Therapeutics Inc. | $5.91M | +230K | 229,857 1.09% of portfolio | medium |
| Q2 2026 as of | Trim | Biogen Inc. | $-5.42M | -25K -34.13% | 48,400 1.92% of portfolio | medium |